The way property values are displayed:
The way concept relations are shown:
The way concept relations are shown:
Epoprostenol
Hierarchy: | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Epoprostenol ∟ ∟ ∟ ∟ ∟ ∟ ∟ Epoprostenol ∟ ∟ ∟ ∟ ∟ ∟ ∟ Epoprostenol ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Epoprostenol ∟ ∟ ∟ ∟ ∟ ∟ ∟ Epoprostenol ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Epoprostenol X |
Broader terms: | |
Annotation: | /chem syn permitted: do not convert to PROSTAGLANDINS, SYNTHETIC; DF: PGX
X |
History note: | Prostaglandins (1966-1977)X |
historyNote*: | 91(78); was PROSTAGLANDINS X 1978-90 (see under PROSTAGLANDINS 1978-83); PROSTACYCLIN was PROSTACYCLINS 1978-93; PROSTAGLANDIN I2 was PROSTAGLANDINS I2 1982-93; PROSTAGLANDIN X was PROSTAGLANDINS X 1991-93
X |
onlineNote*: | use EPOPROSTENOL to search PROSTAGLANDINS I 1979-93 & PROSTAGLANDINS X 1978-90
X |
publicMeSHNote*: | 91; was PROSTAGLANDINS X 1978-90 (see under PROSTAGLANDINS 1978-83); PROSTACYCLIN was PROSTACYCLINS 1978-93; PROSTAGLANDIN I2 was PROSTAGLANDINS I2 1982-93; PROSTAGLANDIN X was PROSTAGLANDINS X 1991-93
X |
Scope note: | A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY).
X |
activeMeSHYear*: | |
dateCreated*: | 1977-05-23X |
dateEstablished*: | 1984-01-01X |
dateRevised*: | 2005-06-30X |
recordAuthorizer*: | sjnX |
recordMaintainer*: | ssbX |
recordOriginator*: | RLSX |
Type: | |
URI: | |
Labels and equivalent concepts: | Epoprostenoli (fi) XProstaglandin I(2) (en, replaced) Prostaglandin I2 (en, replaced) Prostacyclin (en, replaced) PGX (en, replaced) PGI2 (en, replaced) Epoprostanol (en, replaced) |
Share: |
Loading results...